Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Izumi Hamada

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 8, 2014
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes MellitusMasato Odawara, Izumi Hamada, Manabu Suzuki
Clinical Pharmacology in Drug Development|January 6, 2022
Pharmacokinetics, Safety, and Tolerability of NPC-21, an Anti-Cytomegalovirus Monoclonal Antibody, in Healthy Japanese and White Adult Men: A Randomized, Placebo-Controlled, First-in-Human Phase 1 StudyKenichi Furihata, Izumi Hamada, Takuro Niwa, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 19, 2015
Efficacy and safety of a single-pill combination of vildagliptin and metformin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trialMasato Odawara, Mika Yoshiki, Misako Sano, et al.
The Journal of Dermatology|April 15, 2024
Validation of the Index for Facial Angiofibromas: Data analysis from a randomized controlled trial of sirolimus gel treatment in patients with tuberous sclerosis complexIzumi Hamada, Yoshinori Yukutake, Yusuke Morita, et al.
Scientific Reports|February 2, 2024
Demographic and clinical characteristics of patients with zinc deficiency: analysis of a nationwide Japanese medical claims databaseHirohide Yokokawa, Yusuke Morita, Izumi Hamada, et al.
Journal of Autism and Developmental Disorders|June 28, 2021
Melatonin Treatment and Adequate Sleep Hygiene Interventions in Children with Autism Spectrum Disorder: A Randomized Controlled TrialMasaharu Hayashi, Kazuo Mishima, Michio Fukumizu, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|December 20, 2024
Randomized, multicenter, active-controlled open-label study of NPC-25, zinc histidine hydrate, (non-inferiority to NOBELZIN™, zinc acetate dihydrate) for patients with hypozincemiaDaisuke Asaoka, Tomomi Ishihara, Sachiko Ezoe, et al.
BMC Psychiatry|September 11, 2020
Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disordersKotaro Yuge, Shinichiro Nagamitsu, Yuko Ishikawa, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 20, 2024
Novel endpoints based on tumor size ratio to support early clinical decision-making in oncology drug-developmentShubhadeep Chakraborty, Kshitij Aggarwal, Marzana Chowdhury, et al.
JAMA Dermatology|May 26, 2018
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical TrialMari Wataya-Kaneda, Yuuki Ohno, Yasuyuki Fujita, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 8, 2014
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes MellitusMasato Odawara, Izumi Hamada, Manabu Suzuki
Clinical Pharmacology in Drug Development|January 6, 2022
Pharmacokinetics, Safety, and Tolerability of NPC-21, an Anti-Cytomegalovirus Monoclonal Antibody, in Healthy Japanese and White Adult Men: A Randomized, Placebo-Controlled, First-in-Human Phase 1 StudyKenichi Furihata, Izumi Hamada, Takuro Niwa, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 19, 2015
Efficacy and safety of a single-pill combination of vildagliptin and metformin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trialMasato Odawara, Mika Yoshiki, Misako Sano, et al.
The Journal of Dermatology|April 15, 2024
Validation of the Index for Facial Angiofibromas: Data analysis from a randomized controlled trial of sirolimus gel treatment in patients with tuberous sclerosis complexIzumi Hamada, Yoshinori Yukutake, Yusuke Morita, et al.
Scientific Reports|February 2, 2024
Demographic and clinical characteristics of patients with zinc deficiency: analysis of a nationwide Japanese medical claims databaseHirohide Yokokawa, Yusuke Morita, Izumi Hamada, et al.
Journal of Autism and Developmental Disorders|June 28, 2021
Melatonin Treatment and Adequate Sleep Hygiene Interventions in Children with Autism Spectrum Disorder: A Randomized Controlled TrialMasaharu Hayashi, Kazuo Mishima, Michio Fukumizu, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|December 20, 2024
Randomized, multicenter, active-controlled open-label study of NPC-25, zinc histidine hydrate, (non-inferiority to NOBELZIN™, zinc acetate dihydrate) for patients with hypozincemiaDaisuke Asaoka, Tomomi Ishihara, Sachiko Ezoe, et al.
BMC Psychiatry|September 11, 2020
Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disordersKotaro Yuge, Shinichiro Nagamitsu, Yuko Ishikawa, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 20, 2024
Novel endpoints based on tumor size ratio to support early clinical decision-making in oncology drug-developmentShubhadeep Chakraborty, Kshitij Aggarwal, Marzana Chowdhury, et al.
JAMA Dermatology|May 26, 2018
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical TrialMari Wataya-Kaneda, Yuuki Ohno, Yasuyuki Fujita, et al.
Pageof 2